3-[(6-Chloropyridin-2-yl)amino]-3H,4H-thieno[3,2-d]pyrimidin-4-one

Catalog No. :
ACXOEH484
CAS No. :
338750-86-0
Molecular Formula :
C11H7ClN4OS
Molecular Weight :
278.72

IUPAC Name:3-((6-chloropyridin-2-yl)amino)thieno[3,2-d]pyrimidin-4(3H)-one

3-[(6-Chloropyridin-2-yl)amino]-3H,4H-thieno[3,2-d]pyrimidin-4-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$506.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-[(6-Chloropyridin-2-yl)amino]-3H,4H-thieno[3,2-d]pyrimidin-4-one
IUPAC Name3-((6-chloropyridin-2-yl)amino)thieno[3,2-d]pyrimidin-4(3H)-one
MDL No.MFCD00138938
Molecular FormulaC11H7ClN4OS
Molecular Weight278.72
SMILESO=C1C2=C(C=CS2)N=CN1NC3=NC(Cl)=CC=C3
InChI KeyUQEUCLBLEOLLOB-UHFFFAOYSA-N
Synonym3-[(6-chloropyridin-2-yl)amino]-3H,4H-thieno[3,2-d]pyrimidin-4-one;3-[(6-CHLORO-2-PYRIDINYL)AMINO]THIENO[3,2-D]PYRIMIDIN-4(3H)-ONE;Thieno[3,2-d]pyrimidin-4(3H)-one, 3-[(6-chloro-2-pyridinyl)amino]-
CAS No.338750-86-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACXOEH484 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBOTL036 route compound structure diagram
    ACBOTL0365140-72-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXOEH484 route product structure diagram
    ACXOEH484338750-86-0
Inquiry

2. ACXOEH484 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCAJG934 route compound structure diagram
    ACCAJG934258506-66-0 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXOEH484 route product structure diagram
    ACXOEH484338750-86-0
Inquiry

Comments (0)